Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cinnamon bark essential oil is a volatile oil extracted from the bark of Cinnamomum species (commonly Cinnamomum zeylanicum, also known as Ceylon cinnamon). The oil is characterized by a high content of **cinnamaldehyde** (typically 60–91%), along with minor constituents such as linalool, β-caryophyllene, eucalyptol, eugenol, p-cymene, α-humulene, and limonene[1][2][3]. The major pharmacological properties include **antioxidant** and **antimicrobial** effects, particularly against Gram-positive bacteria, largely attributed to cinnamaldehyde[1]. Mechanistically, the oil disrupts bacterial cell membranes and causes leakage of intracellular contents[1]. It also exhibits dose-dependent antiproliferative effects in vitro and has potential as a natural preservative and for medicinal use, though most applications are traditional or for food safety rather than established pharmaceutical indications[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cinnamon bark essential oil.